We are live on
!
Find out more
CII
CR Intrinsic Investors Portfolio holdings
AUM
$2.67B
1-Year Est. Return
28.43%
This Fund
S&P 500
This Quarter
Est. Return
+9.72%
1 Year Est. Return
+28.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.23B
AUM Growth
+$338M
(+12%)
Cap. Flow
+$142M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
13.81%
Holding
482
New
152
Increased
81
Reduced
92
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$48.7M |
| 2 |
Home Depot
HD
|
+$44.7M |
| 3 |
Verizon
VZ
|
+$36.6M |
| 4 |
ESC
EMERITUS CORP
ESC
|
+$28.6M |
| 5 |
Elevance Health
ELV
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$40.2M |
| 2 |
Viatris
VTRS
|
+$37.2M |
| 3 |
Liberty Global Class C
LBTYK
|
+$30.7M |
| 4 |
Crown Castle
CCI
|
+$27.1M |
| 5 |
Amazon
AMZN
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.66% |
| 2 | Healthcare | 13.51% |
| 3 | Industrials | 9.01% |
| 4 | Technology | 8.79% |
| 5 | Materials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELOS
276
DELISTED
Syneron Medical Ltd
ELOS
| $2.33M | 0.07% |
+270,000
| New | +$2.33M |
|
|
MNTA
277
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.3M | 0.07% |
160,000
-90,000
| -36% | -$1.38M |
|
|
SREV
278
DELISTED
ServiceSource International, Inc.
SREV
| $2.29M | 0.07% |
+190,000
| New | +$2.25M |
|
|
BSFT
279
DELISTED
BroadSoft, Inc.
BSFT
| $2.29M | 0.07% |
+63,678
| New | +$2.06M |
|
|
AVP
280
PUT
DELISTED
Avon Products, Inc.
AVP
| $2.27M | 0.07% |
110,000
| – | – |
|
|
BEAM
281
DELISTED
BEAM INC COM STK (DE)
BEAM
| $2.26M | 0.07% |
35,000
-30,000
| -46% | -$1.93M |
|
|
LITB
282
LightInTheBox
LITB
$54.7M
| $2.26M | 0.07% |
31,804
-29,829
| -48% | -$2.56M |
|
283
Lennox International
LII
$14.9B
| $2.26M | 0.07% |
30,000
-20,000
| -40% | -$1.41M |
|
|
MESG
284
DELISTED
XURA INC COM (DE)
MESG
| $2.24M | 0.07% |
70,000
| – | – |
|
285
Community Health Systems
CYH
$400M
| $2.21M | 0.07% |
+64,365
| New | +$2.28M |
|
286
Neurocrine Biosciences
NBIX
$16.5B
| $2.2M | 0.07% |
+194,248
| New | +$2.67M |
|
287
Rithm Capital
RITM
$5.72B
| $2.15M | 0.07% |
162,500
-87,500
| -35% | -$1.15M |
|
|
ELX
288
DELISTED
EMULEX CORP
ELX
| $2.14M | 0.07% |
275,200
+225,200
| +450% | +$1.75M |
|
|
MTEM
289
DELISTED
Molecular Templates, Inc.
MTEM
| $2.11M | 0.07% |
+2,753
| New | +$2.26M |
|
|
ANDV
290
DELISTED
Andeavor
ANDV
| $2.09M | 0.06% |
+47,500
| New | +$2.37M |
|
|
GM.WS.C
291
DELISTED
GENERAL MTRS CO WTS EXP 12/31/15 (DE)
GM.WS.C
| $2M | 0.06% |
+500,000
| New | +$1.99M |
|
|
DTV
292
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.91M | 0.06% |
+32,000
| New | +$1.97M |
|
|
SGNT
293
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.91M | 0.06% |
93,677
-51,473
| -35% | -$1.15M |
|
294
Bunge Global
BG
$21.4B
| $1.9M | 0.06% |
+25,000
| New | +$1.89M |
|
295
PUT
Delta Air Lines
DAL
$59.5B
| $1.89M | 0.06% |
+80,000
| New | +$1.67M |
|
296
Assured Guaranty
AGO
$3.31B
| $1.88M | 0.06% |
100,000
+18,600
| +23% | +$393K |
|
297
CALL
Steel Dynamics
STLD
$37.8B
| $1.84M | 0.06% |
+110,000
| New | +$1.74M |
|
298
Gogo Inc
GOGO
$392M
| $1.78M | 0.06% |
+100,000
| New | +$1.31M |
|
|
TGI
299
DELISTED
Triumph Group
TGI
| $1.76M | 0.05% |
25,000
-75,000
| -75% | -$5.78M |
|
|
CLNY
300
DELISTED
Colony Capital, Inc.
CLNY
| $1.7M | 0.05% |
85,000
-195,000
| -70% | -$3.94M |
|
Similar funds
SCM
SZC
RM
HOAM
SC
G
TT
IPRC
CR Intrinsic Investors's Q3 2013 Portfolio in Review
As of Q3 2013, CR Intrinsic Investors held 482 positions worth $3.23B, up 12% from $2.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
CR Intrinsic Investors deployed $142M of net new capital in Q3 2013, opening 152 new positions and adding to 81 existing holdings. Its largest new stake was Verizon: 750,000 shares worth $35M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $40.2M trimmed.
- CR Intrinsic Investors's largest Q3 2013 buy was Verizon: 750,000 shares worth $35M.
- CR Intrinsic Investors added most to Intuitive Surgical in Q3 2013, an estimated $48.7M increase.
- CR Intrinsic Investors's biggest Q3 2013 reduction was Freeport-McMoran, cutting an estimated $40.2M.
- CR Intrinsic Investors fully exited Viatris in Q3 2013, selling an estimated $37.2M.
- CR Intrinsic Investors's ten largest holdings make up 14% of its $3.23B portfolio in Q3 2013.
- CR Intrinsic Investors opened 152 new positions and closed 138 in Q3 2013.
- CR Intrinsic Investors's portfolio value rose 12% quarter-over-quarter to $3.23B.
Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.